311 related articles for article (PubMed ID: 25858685)
1. Rechallenging 5-Fluorouracil in a Patient With Capecitabine-Induced Ventricular Fibrillation.
Lai S; Marshall JL; Morrissey RL
Clin Colorectal Cancer; 2015 Sep; 14(3):198-201. PubMed ID: 25858685
[No Abstract] [Full Text] [Related]
2. Cardiac arrest and ventricular fibrillation in a young man treated with capecitabine: Case report and literature review.
De Gennaro L; Brunetti ND; Resta M; Rutigliano D; Tarantini L; Caldarola P
Int J Cardiol; 2016 Oct; 220():280-3. PubMed ID: 27390942
[No Abstract] [Full Text] [Related]
3. Capecitabine-induced ventricular fibrillation arrest: Possible Kounis syndrome.
Kido K; Adams VR; Morehead RS; Flannery AH
J Oncol Pharm Pract; 2016 Apr; 22(2):335-40. PubMed ID: 25870182
[TBL] [Abstract][Full Text] [Related]
4. Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm.
Shah NR; Shah A; Rather A
J Oncol Pharm Pract; 2012 Mar; 18(1):132-5. PubMed ID: 21321041
[TBL] [Abstract][Full Text] [Related]
5. A Case of 5-Fluorouracil-Induced Cardiac Arrest.
Ray JC; Cho P; Dragon M; Graham CG
J Emerg Med; 2016 Jan; 50(1):e1-6. PubMed ID: 26482827
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced colorectal cancer in a patient with cardiotoxic reactions to 5-fluorouracil and capecitabine using suboptimal doses.
Cioffi JH; Estes DJ; Florou V; Ardalan B
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29183892
[TBL] [Abstract][Full Text] [Related]
7. Ventricular fibrillation cardiac arrest due to 5-fluorouracil cardiotoxicity.
Fradley MG; Barrett CD; Clark JR; Francis SA
Tex Heart Inst J; 2013; 40(4):472-6. PubMed ID: 24082383
[TBL] [Abstract][Full Text] [Related]
8. [Capecitabine-induced ventricular fibrillation].
van Capelle AV; de Valk J; Schakenraad D; Germans T; Ten Oever D
Ned Tijdschr Geneeskd; 2017; 160():D666. PubMed ID: 28074721
[TBL] [Abstract][Full Text] [Related]
9. [Cardiotoxicity induced by 5-fluorouracil or capecitabine].
Jensen SA; Baeksgaard L; Petersen LN; Reiter L; Sørensen JB
Ugeskr Laeger; 2010 Jan; 172(1):48-51. PubMed ID: 20056096
[TBL] [Abstract][Full Text] [Related]
10. Unilateral Capecitabine-related Hand-foot Syndrome.
Matsuda S; Koketsu H; Hayakawa M; Nagata N
Intern Med; 2015; 54(21):2779. PubMed ID: 26521911
[No Abstract] [Full Text] [Related]
11. Paradoxical effect of capecitabine in 5-fluorouracil-induced cardiotoxicity: A case vignette and literature review.
Saneeymehri SS; Markey KR; Mahipal A
J Oncol Pharm Pract; 2016 Jun; 22(3):552-5. PubMed ID: 25852107
[TBL] [Abstract][Full Text] [Related]
12. Various Manifestations of 5-Fluorouracil Cardiotoxicity: A Multicenter Case Series and Review of Literature.
Allison JD; Tanavin T; Yang Y; Birnbaum G; Khalid U
Cardiovasc Toxicol; 2020 Aug; 20(4):437-442. PubMed ID: 31925673
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer.
Polk A; Shahmarvand N; Vistisen K; Vaage-Nilsen M; Larsen FO; Schou M; Nielsen DL
BMJ Open; 2016 Oct; 6(10):e012798. PubMed ID: 27798021
[TBL] [Abstract][Full Text] [Related]
14. TYMS Gene Polymorphisms in Breast Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy.
Chao YL; Anders CK
Clin Breast Cancer; 2018 Jun; 18(3):e301-e304. PubMed ID: 28899623
[No Abstract] [Full Text] [Related]
15. Rapidly developing heart failure from capecitabine cardiotoxicity: a case study.
Ambesh P; Zivari K; Obiagwu C; Shetty V; Kamholz S; Hollander G; Shani J
Br J Clin Pharmacol; 2018 Apr; 84(4):800-802. PubMed ID: 29336052
[No Abstract] [Full Text] [Related]
16. Capecitabine, a possible reason of sudden cardiac death.
Ridruejo R; Gonzalez C; Jorge R
Med Clin (Barc); 2017 Feb; 148(3):143-144. PubMed ID: 27939916
[No Abstract] [Full Text] [Related]
17. Cardiotoxicity of capecitabine: Captions not to bin.
De Gennaro L; Brunetti ND; Resta M; Rutigliano D; Tarantini L; Caldarola P
Int J Cardiol; 2017 Feb; 229():6. PubMed ID: 27940005
[No Abstract] [Full Text] [Related]
18. Capecitabine-induced hyperglycemia without hyperlipidemia: a case report.
Avishek A; Jayanthi M; Biswajit D
Eur J Clin Pharmacol; 2017 Nov; 73(11):1519-1521. PubMed ID: 28752256
[No Abstract] [Full Text] [Related]
19. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
Karakulak UN; Aladağ E; Maharjan N; Övünç K
Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
[TBL] [Abstract][Full Text] [Related]
20. Alternative treatment options in colorectal cancer patients with 5-fluorouracil- or capecitabine-induced cardiotoxicity.
Deboever G; Hiltrop N; Cool M; Lambrecht G
Clin Colorectal Cancer; 2013 Mar; 12(1):8-14. PubMed ID: 23102544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
